The changes in the carrying value of goodwill for the period presented are as follows (in thousands):


	Carrying Value
Balance as of December 31, 2024	$	112,728
Addition from acquisitions	146,984
Foreign currency translation adjustments	(476)
Balance as of September 30, 2025	$	259,236

Intangible assets, net as of September 30, 2025 consist of the following (in thousands):


	Gross Amount		Accumulated Amortization and Impairment		Net Carrying Value		Weighted Average Remaining Useful Life (Years)
Platform partnerships	$	99,832	$	(2,080)	$	97,752	11.8
Trade name	31,561		(13,062)		18,499		2.5
503B pharmacy license	28,596		(3,098)		25,498		8.9
Other	59,965		(6,783)		53,182		3.5
Intangible assets, net	$	219,954	$	(25,023)	$	194,931	8.2

Intangible assets, net as of December 31, 2024 consist of the following (in thousands):


	Gross Amount		Accumulated Amortization and Impairment		Net Carrying Value		Weighted Average Remaining Useful Life (Years)
503B pharmacy license	$	28,596	$	(953)	$	27,643	9.7
Trade name	24,170		(9,256)		14,914		6.5
Other	4,786		(3,933)		853		6.0
Intangible assets, net	$	57,552	$	(14,142)	$	43,410	8.5

Amortization expense for intangible assets was $9.2 million and $0.9 million for the three months ended September 30, 2025 and 2024, respectively, and $14.1 million and $2.4 million for the nine months ended September 30, 2025 and 2024, respectively.

There were no impairment charges on intangible assets for the three and nine months ended September 30, 2025 and 2024.

Amortization that will be charged to expense over the remaining life of the intangible assets subsequent to September 30, 2025 is as follows (in thousands):


The remainder of 2025	$	9,273
2026	36,447
2027	33,124
2028	21,681
2029	16,047
2030 and thereafter	78,359
	$	194,931